Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction

被引:7
作者
Logstrup, Brian B. [1 ]
Hofsten, Dan E. [1 ]
Christophersen, Thomas B. [1 ]
Moller, Jacob E. [2 ]
Bjerre, Mette [3 ,5 ]
Flyvbjerg, Allan [3 ,5 ]
Botker, Hans E. [4 ,5 ]
Egstrup, Kenneth [1 ]
机构
[1] Odense Univ, Funen Svendborg Hosp, Dept Med Res, DK-5700 Svendborg, Denmark
[2] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[3] Aarhus Univ Hosp Skejby, Dept Internal Med & Endocrinol, Aarhus, Denmark
[4] Aarhus Univ Hosp Skejby, Dept Cardiol, Aarhus, Denmark
[5] Aarhus Univ, Fac Hlth Sci, Dept Clin Med, Aarhus, Denmark
关键词
acute myocardial infarction; coronary flow reserve; echocardiography; microcirculation; osteoprotegerin; SERUM OSTEOPROTEGERIN; GENERAL-POPULATION; CALCIFICATION; ADIPONECTIN; EXPRESSION; MORTALITY; SEVERITY; THERAPY; DISEASE; SYSTEM;
D O I
10.1097/MCA.0b013e328363242e
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Osteoprotegerin (OPG) is a glycoprotein that inhibits nuclear factor-B's regulatory effects on inflammation, skeletal, and vascular systems, and is a potential biomarker of atherosclerosis and seems to be involved in vascular calcifications. The objective of this study was to assess the relationship between OPG, left ventricular function, and microvascular function in patients with acute myocardial infarction (AMI).Patients and methods After successful revascularization, noninvasive assessment of coronary flow reserve (CFR) was performed in the distal part of the left anterior descending artery in 183 patients with first AMI. We performed low-dose dobutamine stress echocardiography to assess viability and finally we assessed the ventriculoarterial coupling (VAC). Plasma OPG was determined by ELISA.Results Plasma OPG concentrations were higher in patients with impaired microcirculation (CFR<2) than in patients without [median (first; third quartile), 1.939 (1.366; 2.724) vs. 1.451 (0.925; 2.164) ng/l; P=0.001]. OPG was associated with CFR both in linear regression single-variable analysis (P=0.001) and in multivariable analysis adjusting for possible confounders (P=0.024).Eighty-seven patients had resting wall motion abnormalities and 28 patients fulfilled the criteria for viability. In the group with low OPG 20 patients had viability, and in patients with high OPG only eight patients had viability (P=0.03).Both the E/A ratio (1.22 +/- 0.65 vs. 1.06 +/- 0.39; P=0.04) and the E/e ratio (10.4 +/- 3.1 vs. 12.2 +/- 4.6; P=0.002) indicated worse diastolic function in patients with increased levels of OPG.Overall, an increase in the VAC point was observed in the population (1.11 +/- 0.6). The VAC point was higher in patients with increased OPG compared with low OPG (1.01 +/- 0.51 vs. 1.2 +/- 0.67; P=0.03).Conclusion This is the first study to show an association between OPG levels and CFR, decreased diastolic function, and increased VAC in the setting of AMI. Our results indicate a relationship between OPG and the degree of microvascular dysfunction.
引用
收藏
页码:487 / 492
页数:6
相关论文
共 30 条
  • [1] The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects
    Anand, DV
    Lahiri, A
    Lim, E
    Hopkins, D
    Corder, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1850 - 1857
  • [2] Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
    Andersen, Geir Oystein
    Knudsen, Eva Cecilie
    Aukrust, Pal
    Yndestad, Arne
    Oie, Erik
    Muller, Carl
    Seljeflot, Ingebjorg
    Ueland, Thor
    [J]. HEART, 2011, 97 (06) : 460 - 465
  • [3] osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
    Bucay, N
    Sarosi, I
    Dunstan, CR
    Morony, S
    Tarpley, J
    Capparelli, C
    Scully, S
    Tan, HL
    Xu, WL
    Lacey, DL
    Boyle, WJ
    Simonet, WS
    [J]. GENES & DEVELOPMENT, 1998, 12 (09) : 1260 - 1268
  • [4] Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise
    Chantler, Paul D.
    Lakatta, Edward G.
    Najjar, Samer S.
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2008, 105 (04) : 1342 - 1351
  • [5] Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men
    Chen, Weena J. Y.
    Rijzewijk, Luuk J.
    van der Meer, Rutger W.
    Heymans, Martijn W.
    van Duinkerken, Eelco
    Lubberink, Mark
    Lammertsma, Adriaan A.
    Lamb, Hildo J.
    de Roos, Albert
    Romijn, Johannes A.
    Smit, Jan W. A.
    Bax, Jeroen J.
    Bjerre, Mette
    Frystyk, Jan
    Flyvbjerg, Allan
    Diamant, Michaela
    [J]. CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [6] Relation of Circulating Osteoprotegerin Levels on Admission to Microvascular Obstruction After Primary Percutaneous Coronary Intervention
    Erkol, Ayhan
    Pala, Selcuk
    Kirma, Cevat
    Oduncu, Vecih
    Dundar, Cihan
    Izgi, Akin
    Tigen, Kursat
    Gibson, C. Michael
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (06) : 857 - 862
  • [7] Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily
    Flyvbjerg, Allan
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (02) : 94 - 101
  • [8] Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population
    Gannage-Yared, Marie-Helene
    Fares, Florence
    Semaan, Michelle
    Khalife, Simon
    Jambart, Selim
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 64 (06) : 652 - 658
  • [9] Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease
    Jono, S
    Ikari, Y
    Shioi, A
    Mori, K
    Miki, T
    Hara, K
    Nishizawa, Y
    [J]. CIRCULATION, 2002, 106 (10) : 1192 - 1194
  • [10] Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease
    Kiechl, S
    Schett, G
    Wenning, G
    Redlich, K
    Oberhollenzer, M
    Mayr, A
    Santer, P
    Smolen, J
    Poewe, W
    Willeit, J
    [J]. CIRCULATION, 2004, 109 (18) : 2175 - 2180